On 27 October 2016
Lincoln Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27 October 2016, to issue and allotment of equity shares against conversion of warrant issue to Promoter/Promoter Group and Non-Promoter warrant holders.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
